DGX QUEST DIAGNOSTICS INC revenue, earnings and financials

For the quarter ended September 30, 2026, QUEST DIAGNOSTICS INC reported revenue of $3.10B (up 10.0% from a year earlier), net income of $312M and diluted EPS of $2.78; over the last four quarters revenue was $11.8B and net income $1.13B; for the fiscal year ended December 2025 revenue was $11.0B, up 11.8% on the year before.

DGX annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $11.0B, gross profit n/a, operating income $1.56B, net income $992M (margin 9.0%), EPS $8.75
• Fiscal year ended Dec 2024: revenue $9.87B, gross profit n/a, operating income $1.35B, net income $871M (margin 8.8%), EPS $7.69
• Fiscal year ended Dec 2023: revenue $9.25B, gross profit n/a, operating income $1.26B, net income $854M (margin 9.2%), EPS $7.49
• Fiscal year ended Dec 2022: revenue $9.88B, gross profit n/a, operating income $1.43B, net income $946M (margin 9.6%), EPS $7.97
• Fiscal year ended Dec 2021: revenue $10.8B, gross profit n/a, operating income $2.38B, net income $2.00B (margin 18.5%), EPS $15.55

DGX quarterly revenue and earnings

• Quarter ended Sep 30, 2026: revenue $3.10B (up 10.0% year over year), net income $312M, EPS $2.78
• Quarter ended Jun 30, 2026: revenue $3.04B (up 10.2% year over year), net income $320M, EPS $2.84
• Quarter ended Mar 31, 2026: revenue $2.90B (up 9.2% year over year), net income $252M, EPS $2.24
• Quarter ended Dec 31, 2025 (from the annual report): revenue $2.81B (up 7.1% year over year), net income $245M, EPS $2.18
• Quarter ended Sep 30, 2025: revenue $2.82B (up 13.2% year over year), net income $245M, EPS $2.16
• Quarter ended Jun 30, 2025: revenue $2.76B (up 15.2% year over year), net income $282M, EPS $2.47
• Quarter ended Mar 31, 2025: revenue $2.65B (up 12.1% year over year), net income $220M, EPS $1.94
• Quarter ended Dec 31, 2024 (from the annual report): revenue $2.62B (up 14.6% year over year), net income $222M, EPS $1.95
• Quarter ended Sep 30, 2024: revenue $2.49B (up 8.4% year over year), net income $226M, EPS $1.99
• Quarter ended Jun 30, 2024: revenue $2.40B (up 2.5% year over year), net income $229M, EPS $2.03
• Quarter ended Mar 31, 2024: revenue $2.37B (up 1.5% year over year), net income $194M, EPS $1.72
• Quarter ended Dec 31, 2023 (from the annual report): revenue $2.29B (down 1.9% year over year), net income $192M, EPS $1.70
• Quarter ended Sep 30, 2023: revenue $2.30B (down 7.7% year over year), net income $225M, EPS $1.96
• Quarter ended Jun 30, 2023: revenue $2.34B (down 4.7% year over year), net income $235M, EPS $2.05
• Quarter ended Mar 31, 2023: revenue $2.33B (down 10.7% year over year), net income $202M, EPS $1.78
• Quarter ended Dec 31, 2022 (from the annual report): revenue $2.33B (down 15.0% year over year), net income $101M, EPS $0.92
• Quarter ended Sep 30, 2022: revenue $2.49B (down 10.4% year over year), net income $256M, EPS $2.17
• Quarter ended Jun 30, 2022: revenue $2.45B (down 3.8% year over year), net income $234M, EPS $1.96
• Quarter ended Mar 31, 2022: revenue $2.61B (down 4.0% year over year), net income $355M, EPS $2.92
• Quarter ended Dec 31, 2021 (from the annual report): revenue $2.74B, net income $390M, EPS $3.11

DGX cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $1.89B, share buybacks $450M
• Fiscal year ended Dec 2024: operating cash flow $1.33B, share buybacks $151M
• Fiscal year ended Dec 2023: operating cash flow $1.27B, share buybacks $275M
• Fiscal year ended Dec 2022: operating cash flow $1.72B, share buybacks $1.41B
• Fiscal year ended Dec 2021: operating cash flow $2.23B, share buybacks $2.20B

DGX balance sheet

• Sep 30, 2026: cash $797M, total assets $17.2B, total liabilities n/a, shareholders' equity $7.63B, long-term debt $5.54B
• Jun 30, 2026: cash $626M, total assets $16.9B, total liabilities n/a, shareholders' equity $7.52B, long-term debt $5.63B
• Mar 31, 2026: cash $393M, total assets $16.7B, total liabilities n/a, shareholders' equity $7.37B
• Dec 31, 2025: cash $420M, total assets $16.2B, total liabilities n/a, shareholders' equity $7.17B, long-term debt $5.17B
• Sep 30, 2025: cash $432M, total assets $16.2B, total liabilities n/a, shareholders' equity $7.26B
• Jun 30, 2025: cash $319M, total assets $16.0B, total liabilities n/a, shareholders' equity $7.23B
• Mar 31, 2025: cash $188M, total assets $15.8B, total liabilities n/a, shareholders' equity $6.93B
• Dec 31, 2024: cash $549M, total assets $16.2B, total liabilities n/a, shareholders' equity $6.78B, long-term debt $5.62B

What is DGX's revenue?

QUEST DIAGNOSTICS INC reported $11.8B of revenue over its last four quarters, through September 30, 2026.

Is DGX profitable?

Yes. QUEST DIAGNOSTICS INC earned $1.13B over the last four quarters.

What is DGX's EPS?

Diluted earnings per share over the last four quarters were $10.04; $2.78 in the latest quarter.

DGX ownership and insider trades · All stocks